Institutional HoldersBeta
Who holds a company, from every 13F filed for the quarter, one row per filer exactly as filed, against the latest share count the company reported.
Share classes (cover page of the 10-Q filed 2026-08-07, as of 2026-08-04)
| Class | Listed | Shares outstanding | Held by 13F filers | % of class | Holders | CUSIP |
|---|---|---|---|---|---|---|
| Common stock | CGTX · NASDAQ | 95,093,746 | 22,587,135 | 23.8% | 66 | 19243B102 |
Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.
Top holders (66 of 66 · 19243B102)
change vs 2026-03-31Exited since 2026-03-31 (13 filers; largest 13 shown)
Large holders from 13D/13G (latest per reporting person, last 2 years)
Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.
| Reporting person | Form | Filed | Event | Shares | % of class |
|---|---|---|---|---|---|
| AARON G.L. FLETCHER | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 6,059,555 | 6.9% |
| BIOS ADVISORS GP, LLC | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 6,032,328 | 6.8% |
| BIOS CAPITAL MANAGEMENT, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 6,032,328 | 6.8% |
| BIOS CLINICAL OPPORTUNITY FUND, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 500,095 | 0.6% |
| BIOS EQUITY COF, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 500,095 | 0.6% |
| BIOS EQUITY PARTNERS III, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 2,658,387 | 3% |
| BIOS EQUITY PARTNERS II, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 368,301 | 0.4% |
| BIOS EQUITY PARTNERS, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 1,081,531 | 1.2% |
| BIOS FUND III, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 309,748 | 0.4% |
| BIOS FUND III NT, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 326,733 | 0.4% |
| BIOS FUND III QP, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 2,021,906 | 2.3% |
| BIOS FUND II, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 78,298 | 0.1% |
| BIOS FUND II NT, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 34,238 | 0.04% |
| BIOS FUND II QP, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 255,765 | 0.3% |
| BIOS FUND I, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 418,926 | 0.5% |
| BIOS FUND I QP, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 245,029 | 0.3% |
| BIOS MEMORY SPV II, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 385,248 | 0.4% |
| BIOS MEMORY SPV I, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 1,424,014 | 1.6% |
| BP DIRECTORS, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 32,328 | 0.04% |
| CAVU ADVISORS, LLC | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 5,532,233 | 6.3% |
| CAVU MANAGEMENT, LP | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 5,532,233 | 6.3% |
| LESLIE W. KREIS | SCHEDULE 13D/A | 2025-09-23 | 2025-09-19 | 5,532,233 | 6.3% |
| PATHSTONE FAMILY OFFICE, LLC | SCHEDULE 13G | 2025-02-04 | 2024-05-23 | 0 | 0% |
Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.